Marafini Irene, Salvatori Silvia, Rocchetti Irene, Alfieri Norma, Scarozza Patrizio, Calabrese Emma, Biancone Livia, Monteleone Giovanni
Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Statistical Office, Superior Council of Judiciary, 00185 Rome, Italy.
J Clin Med. 2021 Mar 12;10(6):1192. doi: 10.3390/jcm10061192.
Ulcerative colitis (UC) and colonic diverticulosis can co-exist in some patients. However, the natural history of UC associated with colonic diverticulosis is not well known. We here compared the disease characteristics and outcome of UC patients with and without concomitant colonic diverticulosis. Medical records of 347 UC patients were included in an observational, retrospective, nested-matched case-control study. Cases were 92 patients with UC and concomitant colonic diverticulosis, while controls were 255 UC patients without concomitant colonic diverticulosis. A propensity score matching (PSM) was used to homogenate cases (n = 92) and controls (n = 153) for age. UC patients with concomitant colonic diverticulosis were less likely to have an extensive disease (25/92, 27.1%) and to experience steroid dependence (8/92, 8.6%) compared to patients without concomitant colonic diverticulosis (70/153, 45.7% and 48/153, 31.3%, respectively; < 0.001). The use of immunosuppressants (9/92, 9.7% vs. 37/153, 24.1%; = 0.007) or biologics (3/92, 3.2% vs. 26/153, 16.9%, < 0.001) was significantly lower in UC patients with concomitant diverticulosis compared to the control group. On multivariate analysis, steroid dependence and extensive colitis were significantly less frequent in UC patients with concomitant colonic diverticulosis compared to UC patients without diverticula. UC patients with coexisting colonic diverticulosis are less likely to have an extensive disease and to be steroid-dependent.
溃疡性结肠炎(UC)和结肠憩室病可在部分患者中共存。然而,与结肠憩室病相关的UC的自然病程尚不清楚。我们在此比较了合并和未合并结肠憩室病的UC患者的疾病特征及转归。一项观察性、回顾性、巢式匹配病例对照研究纳入了347例UC患者的病历。病例为92例合并结肠憩室病的UC患者,对照为255例未合并结肠憩室病的UC患者。采用倾向评分匹配(PSM)法按年龄对病例组(n = 92)和对照组(n = 153)进行同质化处理。与未合并结肠憩室病的患者相比,合并结肠憩室病的UC患者患广泛性疾病(25/92,27.1%)及出现激素依赖(8/92,8.6%)的可能性更低(分别为70/153,45.7%和48/153,31.3%;P < 0.001)。合并结肠憩室病的UC患者使用免疫抑制剂(9/92,9.7% 对37/153,24.1%;P = 0.007)或生物制剂(3/92,3.2% 对26/153,16.9%,P < 0.001)的比例显著低于对照组。多因素分析显示,与无憩室的UC患者相比,合并结肠憩室病的UC患者激素依赖和广泛性结肠炎的发生率显著更低。合并结肠憩室病的UC患者患广泛性疾病及激素依赖的可能性更低。